Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Bioorg Med Chem. 2016 Apr 5;24(17):3947–3952. doi: 10.1016/j.bmc.2016.04.009

Figure 1.

Figure 1

A) HIV-1 replication screening of BPBAs at 10 µM. 3TC and AZT (NRTIs), and Raltegravir and Elvitegravir (integrase inhibitors) served as positive controls. NL-4-3 only represents the U87-CD4/CXCR4 cell line infected with the HIV-1 virus (NL4-3 strain) without addition of compound/inhibitor. B) Dose-dependent inhibition of HIV-1 p24 with BPBA3. AZT and 3TC were used as reference compounds.